Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline resistant and sensitive cell lines. A comparison with verapamil

G.J. Schuurhuis; H.J. Broxterman; J.M. van der Hoeven; H.M. Pinedo; J. Lankelma

Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline resistant and sensitive cell lines. A comparison with verapamil

G.J. Schuurhuis, H.J. Broxterman, J.M. van der Hoeven, H.M. Pinedo, J. Lankelma

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

12 Downloads (Pure)

Original language	English
Pages (from-to)	285-290
Journal	Cancer Chemotherapy and Pharmacology
Volume	20
Publication status	Published - 1987

Access to Document

8249Final published version, 6.13 MB

Cite this

@article{41a301a554854c188f6be3f1c08d0e9f,

title = "Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline resistant and sensitive cell lines. A comparison with verapamil",

author = "G.J. Schuurhuis and H.J. Broxterman and {van der Hoeven}, J.M. and H.M. Pinedo and J. Lankelma",

year = "1987",

language = "English",

volume = "20",

pages = "285--290",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Verlag",

}

Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline resistant and sensitive cell lines. A comparison with verapamil. / Schuurhuis, G.J.; Broxterman, H.J.; van der Hoeven, J.M. et al.

In: Cancer Chemotherapy and Pharmacology, Vol. 20, 1987, p. 285-290.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline resistant and sensitive cell lines. A comparison with verapamil

AU - Schuurhuis, G.J.

AU - Broxterman, H.J.

AU - van der Hoeven, J.M.

AU - Pinedo, H.M.

AU - Lankelma, J.

PY - 1987

Y1 - 1987

M3 - Article

VL - 20

SP - 285

EP - 290

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

ER -